PubMed HealthSearch

SEARCH · PubMed Health

Results for “Angiogenesis Inducing Agents”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

Humoral control of cell proliferation: the role of fibroblast growth factor in regeneration, angiogenesis, wound healing, and neoplastic growth.

The Fibroblast Growth Factor (FGF) is a mitogenic agent in the brain and pituitary of mammals. Recent investigations of the effect of FGF on diverse cell types has shown that FGF stimulates the division of cells from a wide variety of tissues of mesodermal origin including fibroblasts, chondrocytes, myoblasts, smooth muscle cells, glial cells, normal adrenal cells, and the Y1 adrenal cell line. Cell types of endodermal or ectodermal origin do not appear to be sensitive to FGF. Since FGF can be found in neural tissues and since it induces the proliferation of two cell types involved in the formation of regeneration blastemas (chondrocytes and myoblasts), we have investigated the possibility that FGF could be similar or identical to the neurotrophic factors present in nerve and responsible for the regeneration of limbs in lower vertebrates. Our results have shown that FGF could indeed substitute for the neurotropic factor and replace the nerves in inducing blastema formation and sustaining proliferation of mesenchymal cells which can differentiate into chrondrocytes and myoblasts. Since the blastema has been described as a benign tumor, the role of FGF in the formation of blastemas and benign tumors is currently under investigation. In addition to stimulating fibroblasts, FGF also has a striking growth-promoting effect on primary cultures of vascular endothelial cells. This suggests that FGF could be an angiogenesis factor. Thus, FGF, one of the most potent mitogenic agents found in tissue extracts has two properties expected of an agent which could induce tumors: it can induce blastema formation (direct mitogenic effect) and, through its mitogenic effect on endothelial cells, it could induce formation of capillaries (amplification step), permitting unlimited growth. Repair processes under FGF control will, under normal circumstances, lead to wound healing. In contrast, if cells become transplanted to the wrong environment (hormonal imbalance), growth factors such as FGF could make them proliferate in an anarchic way since negative feedback from surrounding cells will be lacking.

Angiogenesis Inducing Agents

Blood vascular system in cancer of the larynx.

Injection methods were used for the study of the blood vascular system in 50 specimens from total or subtotal laryngectomy in patients with extensive cancer of the larynx, and in 24 normal postmortem larynges. All specimens were injected via the superior laryngeal arteries. A silicone rubber technique was found to be the most suitable for the aims of this study. A chaotic distribution of abnormal vessels that differ in shape, a rich neovascular network within the tumor, and capillary hypertrophy in its vicinity are the main features of the blood vascular system in laryngeal cancer. The results obtained indicate great tumor-angiogenic ability that can be indirectly explained by action of an angiogenesis factor diffusing from cancer cells. This may open new possibilities for the treatment of carcinoma of the larynx based on anti-angiogenesis.

Aged

Tumour angiogenesis factor (TAF) in human and animal tumours.

Extracts were made from Walker 256 carcinoma, spontaneous rat mammary adenocarcinoma, Wilms' tumour, human neuroblastoma and human haemangioma. Chromatography of the extracts on Sephadex G-100 yielded four fractions, A, B, C and D. Injection of fractions B and C resulted in the growth of new capillaries in the subcutaneous fascia or rats. Controls, e.g. similar extracts of rat liver or human kidney, did not induce neovascularisation. The endothelium of newly-formed blood vessels contained many mitotic figures. A limitation of this method is that it is qualitative only. In order to develop a quantitative in vitro assay for a tumour angiogenesis factor (TAF), short-term primary cultures were initiated from adult rat brain white matter, as cells from such cultures were shown to be vascular in origin. Addition of fractions containing TAF (B and C) which were active in vivo failed to stimulate thymidine uptake by the cells. The possible reasons for this failure and the therapeutic potential of TAF in cancer control are discussed.

Adenocarcinoma

Mast cells and tumor angiogenesis.

Tumor angiogenesis factor (TAF) elicits a strong vasoproliferative response when implanted upon the chorioallantoic membrane (CAM) of the chick embryo. This response is first observed stereomicroscopically 2-3 days after implantation. A 40-fold increase in mast cell density is observed within the vicinity of this implant by 24 h. Mast cells that have been isolated from retired breeder Sprague-Dawley rats fail to evoke a vascular reaction when implanted on the CAM. An intermediate role for the mast cell in tumor angiogenesis is suggested.

Angiogenesis Inducing Agents

Tumour angiogenesis factor (TAF) and its neutralisation by a xenogeneic antiserum.

Tumour angiogenesis factor (TAF) has been extracted from a variety of animal and human tumours. Its ability to induce neovascularization in two bioassays, viz. rat air-sac and chick chorioallantoic membrane, is demonstrated. Similar extracts from normal tissues fail to induce angiogenesis. TAF extracts have been used to raise a xenogeneic antiserum, the specificity of which was investigated using classical immunological methods. Its ability to neutralize the biological activity of TAF using the two in vivo assays, was also demonstrated.

Allantois

Importance of a collagen substratum for stimulation of capillary endothelial cell proliferation by tumour angiogenesis factor.

Tumour extracts were obtained from rat Walker 256 carcinoma and examined for the presence of tumour angiogenesis factor (TAF) in vivo before being used in tissue culture experiments. Capillary endothelial cells derived from cow brain white matter were used to study the effects of TAF-containing tumour extracts on cell proliferation in vitro. The cells were grown on two types of substrata: (1) plastic tissue culture dishes and (2) hydrated gels made of rat tail tendon type I collagen. Human platelets or platelet-released factors were introduced into the system because of the many inter-relationships known to exist between platelets, collagen and endothelial cells. If trypsin was used during the preparation of TAT, the resulting batches stimulated endothelial cell proliferation only when the cells were growing on a collagen substratum and either platelets or platelet-released factors were present in the growth medium. If incubation with trypsin was omitted from the TAF extraction procedure, the resulting batches stimulated cell growth both on plastic and on collagen. A synergistic interaction also occurred between these TAF-containing tumour extracts and platelet-released factors. This effect was always more marked when the cells were growing on collagen than when on plastic. These data suggest that the nature of the substratum affects the response of the endothelial cells to TAF and to platelet-released factors.

Angiogenesis Inducing Agents

Angiogenic activity in culture supernatant of antigen-stimulated lymph node cells.

The culture supernatant of antigen- and phytohaemagglutinin-stimulated lymph node cells contained angiogenic activity when applied to hamster cheek pouch vascular membranes. New capillary growth was observed about 7 days after such application. This activity was generated by culturing lymph node cells with antigens for at least 12 hr, while migration inhibitory factor (MIF) was detected in the culture supernatant of 6 hr cultures. The angiogenic activity was separated from blastogenic activity, clot-promoting activity and antibody activity. However, it was not completely separated from MIF by gel-filtration. The molecular weight of the angiogenic activity was estimated to be between 35,000 and 55,000 daltons.

Angiogenesis Inducing Agents

Comparative histological studies of regional lymph nodes of 201 melanoma patients. (Microscopic features in relation to individual age, site, and metastatic spread).

Since May 1968 a total of 2.108 regional lymph nodes (l.n.) dissected from 201 melanoma patients (86 axillary, 107 groin, and 8 neck) have become available for study. The purpose was to detect histological differences between the l.n. of 134 patients lacking and those of 67 patients exhibiting l.n. metastases, histologically verified in 104 of 706 nodes. The main finding is a more than six-fold increase in number and an eleven-fold increase in total area (evaluated by a microscope micrometer) of germinal centers in the lymph follicles of patients with, as compared to those without, l.n. metastases (P less than or equal to 0.05). Paracortical areas were found to be diminished in 56.7% of cases with metastatic spread. Accumulations of plasma cells were mainly seen in the nodes of elderly patients (48.4%) and of those exhibiting regional metastases (47.8%). The observation of numerous and dilated blood vessels in the interfollicular regions noticeably corresponded to the occurrence of lymphatic metastases (P less than or equal to 0.01), suggesting a "tumor angiogenic factor". A negative correlation with metastatic involvement was found as to histiocytosis of marginal sinuses and with respect to the observed fibrinoid hyalinosis of pulp vessels (P less than or equal to 0.01). The marked hyperplasia of lymph node B-lymphocyte regions as opposed to diminished T-lymphocyte areas prevailing in cases with metastatic melanoma is in accord with findings of humoral immunologic blocking activity and impaired T-cell response in advanced malignant melanoma.

Adolescent

Experimental retinal neovascularization induced by intravitreal tumors.

Adult rabbit retinal vessels underwent neovascularization in response to tumor implantation within the vitreous body. The neovascular response was presumably elicited by the tumor angiogenesis factor (TAF). The response of adult retinal vessels to an angiogenic stimulus raises the possibility that a similar substance may cause retinal neovascularization in humans, and that in normal conditions the vitreous may be able to suppress angiogenic activity.

Angiogenesis Inducing Agents

Neovasculogenesis. Triggering factors and possible mechanisms.

The possible regulating mechanism(s) of neovascularization are discussed. Experimental data supporting the view that ocular neovascularization might be triggered by a fundamental metabolic mechanism are presented. Based on his own data and scattered evidence from the literature, the author suggests a model for a possible regulating mechanism of the neovascular process in which the prostaglandins fulfill the role of neovascular mediating substances. Preliminary results demonstrating that indomethacin limits the extent of the neovascular process support this concept and may have a therapeutic implication. Further studies are in progress in order to better understand the pivotal role fulfilled by the prostaglandins in neovasculogenesis.

Angiogenesis Inducing Agents